Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksEMCURE
resources
EMCURE

Emcure Pharmaceuticals Ltd.

NSE: EMCURE
BSE: 544210
Sector: Healthcare
Industry: Pharmaceuticals
1,925.80-1.0 (-0.05%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

Emcure Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual Reports—FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations—

Corporate Announcements and Regulatory Filings

Emcure Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General1 Sept 2026
    Intimation Under Regulations 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Dispatch of letter to the members whose e-mail addresses are not registered with the Company/Depository Participants
  2. Analyst / Investor Meet1 Sept 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Investor Meet on Friday, September 04, 2026
  3. Credit Rating1 Sept 2026
    Announcement under Regulation 30 (LODR)-Credit Rating
    Reaffirmation of Credit Ratings by CARE Ratings Limited
  4. Newspaper Publication29 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information
  5. Business Responsibility and Sustainability Reporting (BRSR)28 Aug 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report for the Financial Year 2025-26
  6. AGM28 Aug 2026
    Notice Of The 45Th Annual General Meeting
    Notice of the 45th Annual General Meeting of Emcure Pharmaceuticals Limited
  7. Reg. 34 (1) Annual Report28 Aug 2026
    Reg. 34 (1) Annual Report.
    Annual Report of the Company for the Financial Year 2025-26
  8. Allotment of ESOP / ESPS25 Aug 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 19,100 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
  9. Analyst / Investor Meet12 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Transcript of Earnings Call - Q1 FY27
  10. General8 Aug 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
    Update on USFDA inspection at our formulations facility located at Sanand, Ahmedabad, Gujarat, India
  11. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Analyst/ Investor Meet on Tuesday, September 22, 2026
  12. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Analyst/ Investor Meet on Thursday, September 17, 2026
  13. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Analyst/ Investor Meet on Tuesday, September 01, 2026
  14. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Analyst/ Investor Meet on Tuesday, August 18, 2026
  15. Analyst / Investor Meet7 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Analyst/Investor Meet on Wednesday, August 12, 2026
  16. Newspaper Publication7 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026
  17. Analyst / Investor Meet6 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of Earnings Call - Q1 FY27
  18. Record Date6 Aug 2026
    Intimation Of Date Of The 45Th Annual General Meeting And Record Date
    Intimation of date of the 45th Annual General Meeting and Record Date for payment of Final Dividend on Equity Shares for the Financial Year March 31, 2026
  19. Change in Management6 Aug 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Change in composition of the Board of the Company
  20. Outcome of Board Meeting6 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 06, 2026
    Outcome of Board Meeting held on August 06, 2026

Frequently Asked Questions

Where can I download the annual report of Emcure Pharmaceuticals Ltd.?
Annual reports of Emcure Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Emcure Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Emcure Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Emcure Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Emcure Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Emcure Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Emcure Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Emcure Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Emcure Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Emcure Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Emcure Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Emcure Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Emcure Pharmaceuticals Ltd. is INE168P01015. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Emcure Pharmaceuticals Ltd. listed?
Emcure Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is EMCURE and the BSE code is -.
Where can I find the shareholding pattern of Emcure Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Emcure Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Emcure Pharmaceuticals Ltd. on Sharpely?
Share price data for Emcure Pharmaceuticals Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.